中医杂志（英文版）2025，Vol.45Issue(5)：1059-1066,8.DOI:10.19852/j.cnki.jtcm.2025.05.012
Jingui Shenqi pill(金匮肾气丸)treats cardiorenal syndrome by inhibiting mitogen-activated protein kinase signaling pathway and reducing inflammatory response
Jingui Shenqi pill(金匮肾气丸)treats cardiorenal syndrome by inhibiting mitogen-activated protein kinase signaling pathway and reducing inflammatory response
摘要
关键词
cardiorenal syndrome/mitogen-activated protein kinase/inflammatory cytokines/signal transduction/Jingui Shenqi pillKey words
cardiorenal syndrome/mitogen-activated protein kinase/inflammatory cytokines/signal transduction/Jingui Shenqi pill引用本文复制引用
HUANG Shuyan,DING Xinyue,ZHANG Hui,LIU Zongjun,LUAN Yuling,XING Lina..Jingui Shenqi pill(金匮肾气丸)treats cardiorenal syndrome by inhibiting mitogen-activated protein kinase signaling pathway and reducing inflammatory response[J].中医杂志（英文版）,2025,45(5):1059-1066,8.基金项目
Supported by Shanghai Putuo District Health System Science and Technology Innovation Project:Study on the Effect and Mechanism of Jinkui Shenqi Pills on Renal Water Metabolism via provirus integration site for moloney murine leukemia virus 3/aquaporin 2 Regulation(No.PTKWS202104) （No.PTKWS202104）
Chengdu University of Traditional Chinese Medicine"Xinglin Scholar"Discipline Talent Research Enhancement Plan:Based on provirus integration site for moloney murine leukemia virus 3 to Explore the Molecular Mechanism of Jingui Shenqi pill in Regulating Water Metabolism in Renal Tubular Cells(No.YYZX2022165) （No.YYZX2022165）
the Clinical Advantage Discipline of Health System of Putuo District in Shanghai(2019ysxk01) （2019ysxk01）
